Fluid Restriction: Time to Let it Flow?

      Fluid restriction has been part of medical practice as a therapeutic intervention for volume-overloaded states since the 19th century. Has the time come to let this central tenet melt into the past like ice in the spring?
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Johansson P
        • Wal MH van der
        • Strömberg A
        • Waldréus N
        • Jaarsma T
        Fluid restriction in patients with heart failure: how should we think?.
        Eur J Cardiovasc Nurs. 2016; 15: 301-304
        • Li Y
        • Fu B
        • Qian X
        Liberal versus restricted fluid administration in heart failure patients.
        Int Heart J. 2015; 56: 192-195
        • Travers B
        • O'Loughlin C
        • Murphy NF
        • Ryder M
        • Conlon C
        • Ledwidge M
        • et al.
        Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability.
        J Card Fail. 2007; 13: 128-132
        • Clark WF
        • Sontrop JM
        • Huang S-H
        • Gallo K
        • Moist L
        • House AA
        • et al.
        Effect of coaching to increase water intake on kidney function decline in adults with chronic kidney disease.
        JAMA. 2018; 319 (Available from): 1870-1871
        • McDonald M
        • Virani S
        • Chan M
        • Ducharme A
        • Ezekowitz JA
        • Giannetti N
        • et al.
        CCS/CHFS Heart Failure Guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction.
        Can J Cardiol. 2021; 37: 531-546
        • McDonagh TA
        • Metra M
        • Adamo M
        • Gardner RS
        • Baumbach A
        • Böhm M
        • et al.
        2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC.
        Eur Heart J. 2021; : ehab368
        • Tsutsui H
        • Ide T
        • Ito H
        • Kihara Y
        • Kinugawa K
        • Kinugawa S
        • et al.
        JCS/JHFS 2021 Guideline focused update on diagnosis and treatment of acute and chronic heart failure.
        J Card Fail. 2021; 27: 1404-1444